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Abstract 
Recently the patient-centered medical home (PCMH) model has become a popular team-based approach 
focused on delivering more streamlined care to patients. In current practices of medical homes, a clini-
cal-based prediction frame is recommended because it can help match the portfolio capacity of PCMH 
teams with the actual load generated by a set of patients. Without such balances in clinical supply and 
demand, issues such as excessive under and over utilization of physicians, long waiting time for receiving 
the appropriate treatment, and non-continuity of care will eliminate many advantages of the medical home 
strategy. In this paper, by extending the hierarchical generalized linear model to include multivariate re-
sponses, we develop a clinical workload prediction model for care portfolio demands in a Bayesian 
framework. The model allows for heterogeneous variances and unstructured covariance matrices for nest-
ed random effects that arise through complex hierarchical care systems. We show that using a multivari-
ate approach substantially enhances the precision of workload predictions at both primary and 
non-primary care levels. We also demonstrate that care demands depend not only on patient de-
mographics but also on other utilization factors, such as length of stay. Our analyses of a recent data from 
Veteran Health Administration further indicate that risk adjustment for patient health conditions can con-
siderably improve the prediction power of the model. 
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1   Introduction 
Health care delivery is a complex multi-level system in which primary care is the base level and acts as a 
principal point of consultation for patients. The traditional format of primary care is mainly featured by 
primary care physicians (PCP), in which each PCP has a designated set of patients, called a patient panel. 
In current practices of most providers, the panel is simply decided by a predetermined maximum size; that 
is when the quota is reached, no more patients will be added [1,2]. Typical panel sizes range from 1200 to 
1600 patients. However, this number alone cannot reflect the actual health workload generated in the pan-
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el. For example, a PCP with 1200 young and healthy patients might be generally under-utilized, while one 
with 1200 elderly patients having multiple comorbidities may experience excessive workload, causing 
long delays in its panel appointment times and forcing patients to switch their PCPs. It is found that many 
factors such as patient’s age, gender, health status and insurance plan can influence the required 
healthcare workload. Ostbye and colleagues [3] find that patients with different chronic diseases regularly 
have different visiting frequencies to their PCPs. Naessens and colleagues [4] discover that the number of 
chronic conditions in a patient will significantly affect clinical workload and medical cost. Potts and 
colleagues [5] propose a risk-standard method to adjust the panel size for each PCP calculating disease 
burden of each physician panel for six chronic diseases. However, there is no description or proof about 
how the risk values are assigned. Balasubramanian and colleagues [6] apply classification and regression 
trees (CART) to classify approximately 20,000 patients at the Mayo Clinic of Rochester, Minnesota, into 
28 categories by using age and gender as factors, so that each category has different workload patterns.  
In recent years, the patient-centered medical home (PCMH) has been introduced as a prominent inter-
vention to improving the US primary care systems with better-quality outcomes at lower costs [7]. This 
model consists of different health professionals grouped together to provide comprehensive, coordinated, 
accessible and cost effective care while maintaining high levels of service quality and stability. Each team 
consists of a group of medical professionals such as primary care provider, registered nurse, nutritionist, 
social worker, and medical clerk that are well poised to provide many aspects of primary care. Theoreti-
cally, medical homes are composed of “joint principles” that ideally complement one another and feed 
into a comprehensive vision of appropriate primary care delivery. The principles are consisted of having a 
personal physician with an ongoing relationship, a whole person orientation care for all stages of life, a 
physician-directed medical practice taking responsibilities for all of the continuing care, a coordinated 
and/or integrated care system across all elements of the care systems, a continuous emphasis on quality 
and safety, an enhanced access to care through such systems as open scheduling and expanded hours, and 
finally an appropriate payment system that recognize the added value provided to PCMH patients [8]. 
Augmented with modern health information technology, the PCMH is crafted to initiate numerous re-
forms in health care delivery and reimbursement systems [9].  
As of 2007, there was some literature examining the prevalence and effectiveness of medical homes. 
For instance, Fisher [10] outlined some recommendations for the success of medical homes such as in-
creasing effective communication and sharing of information across health care providers, broadening the 
medical performance measures to include patients’ experience with care and ordinary assessment of out-
comes, and establishment of medical-home payment system that share savings among all providers in-
volved. A survey by Commonwealth Fund of 3,535 US adults found that when they were provided with a 
medical home, racial and ethnic disparities in care access and quality were substantially reduced [11]. 
Furthermore, having a medical home was associated with more preventive screenings and better man-
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agement of chronic conditions. The Centers for Medicare & Medicaid Services (CMS) planned to pursue 
Medicare pilot projects in 400 practices in 8 regional sites, and by 2009, twenty bills promoting the 
PCMH concept have been successfully introduced in 10 states [12]. Another study within the Group 
Health system in Seattle showed that a medical home prototype led to 29% fewer emergency visits, 6% 
fewer hospitalizations, and total savings of $10.30 per patient per month over a twenty-one month period 
[13]. Bates and Bitton [14] indicated seven health information technology domains deemed to be critical 
for the success of the PCMH model including telehealth, measurement of quality and efficiency, care 
transitions, personal health records, and, most importantly, registries, team care, and clinical decision 
support for chronic diseases. The research also found that access to medical home is associated with low-
er readmission rates among inpatients [13,15].      
Practically, as of December 2009, there were about 26 pilot projects involving medical home being 
directed in 18 states. These consist of over 14,000 physicians and approximately 5 million patients [16]. 
Of interest, Veterans Health Administration (VHA) launched a nationwide 3-year program in April 2010 
to create PCMHs in more than 900 primary care clinics. Early results indicated dramatic improvements 
such as reducing the appointment waiting time from as long as 90 days down to one day and decreasing 
the percentage of inappropriate emergency department visits from 52% to 12% [17].  
However, there are difficulties in fully achieving the benefits of the PCMH in practice. Rittenhouse, 
Shortell [12] point out that much work is needed for the PCMH model to fully leverage the electronic 
clinical information technology, and to develop new business rules and staffing structures before the an-
ticipated cost savings will take place. From an operations management point of view, one of the key suc-
cess factors of any health delivery system is achieving a balance between supply and demand of care ser-
vices. This issue is even more critical for the PCMH model since the clinical supply and demand is port-
folio (vector) in nature. Unlike health demands, the supply of healthcare services can be treated as deter-
ministic and calculated easily based on head counts and available service hours to be offered from all pro-
fessional lines on an annual basis. Yet, the estimation of clinical workload portfolio based on key patient 
and provider attributes is a challenging task and to our knowledge there is no related literature tackling 
this problem in a team based medical home perspective. 
Looking retrospectively at data sets of our US Department of Veteran Affairs (VA) sponsored PCMH 
project, we observe some structural properties listed as follows: 
 Patients (unit of analysis) are grouped within PCMH teams and within VA medical facilities with 
related patient-level, team-level, and also facility-level predictors. In addition, there exists signifi-
cant heteroscedasticity within each level of hierarchy.  
 The actual health workload (outcome) is captured with two variables, one for primary care and one 
for non-primary care, and these are correlated at some levels of hierarchy. 
 Distributions of both outcomes are not normal at all levels of hierarchy.  
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In this paper, we develop a multivariate hierarchical based portfolio prediction model that takes into ac-
count postulated attributes from different levels such as disease types (patient-level), years of experience 
of the assigned provider (team-level), and zip-code based distance between the patient’s home and his/her 
assigned facility (facility-level). We also want to propose an intensity score for panel size and staffing 
level adjustment used at different levels of hierarchy, as it would help decision makers on their PCMH 
team allocation and budget policy decisions. Finally, we seek to screen highly contributing risk factors to 
demand portfolio variations, since it would inform program analysts on areas more likely affecting the 
care portfolio balance. 
To the best of our knowledge, our work is the first attempt to develop such a clinical portfolio predic-
tion model for medical homes within the OR/MS community. Our contributions include extending the 
hierarchical generalized linear model to include multivariate response variables in a Bayesian framework, 
presenting a Markov chain Monte Carlo algorithm with novel prior specifications to fit the model, and 
utilizing our proposal on real data from VHA to produce findings that have key public and medical impli-
cations. Also our approach allows for passing heterogeneous variances and unstructured covariance ma-
trices for the nested random effects as well as their interactions with responses and covariates simultane-
ously. 
The remainder of this paper is laid out as follows. Section 2 introduces our data sources and study 
variables. Section 3 describes the main methodology with detailed inference and model fitting strategies. 
In Section 4 we demonstrate the effectiveness of our proposal with a recent case study from VHA. Some 
discussion points and future research directions are presented in Section 5.  
2  Data Source and Study Variables 
According to National Center for Veterans Analysis and Statistics (NCVAS), VA operates the largest 
health care system in the USA with 23 geographically different regions (known as VISNs, or Veterans 
Integrated Service Networks) separated hierarchically within each VISN by level of care or type into dif-
ferent facilities such as VA medical centers (VAMC), Community Based Outpatient Clinic (CBOC), Vet 
Center (VC), and so forth. Within each facility, every VA primary care enrollee was assigned to an inde-
pendent physician or non-physician PCP by a standard process-VA Primary Care Management Module. 
To ensure sufficient staffing and quality of care, each PCP was appointed a target panel size, taking into 
account the intensity of primary care visits and availability of resources such as supporting staff and capi-
tal. 
In this study we collected outpatient data from a random sample of 888 different facilities (which cor-
responds to 130 VAMCs of all 23 VISNs) during FY11 quarter 3 to FY12 quarter 2. The period of one 
year is appropriate; according to the VA program professionals, the primary care population at each prac-
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tice site is not subject to drastic change from one year to the next. The Decision Support System (DSS) 
and National Patient Care Database (NPCD) files of the VA Corporate Data Warehouse (CDW) were 
employed to extract demographic, socioeconomic, and other types of variables. In addition, due to its rig-
orous data validity and availability, we chose DRG (Diagnosis Related Group, 29
th
 version) and its ACC 
(Aggregated Condition Category) codes for patient case-mix and risk adjustment measures in our predic-
tive analytics [18]. 
Initially there were 82,000 randomly selected patients with 48 independent attributes coded. All pa-
tient visits to primary care and women’s health are assembled for a total capture period of one year. Visits 
from other primary care related clinics, such as Internal Medicine or Geriatric Primary Care, are excluded 
from the analysis. The two dependent variables are total primary care and non-primary care Relative Val-
ue Units (or RVUs), and for each unique SSN, they are calculated by converting the primary care and 
non-primary care Current Procedural Terminology (or CPT) codes from all patient visits during the fiscal 
year (according to Centers for Medicare and Medicaid Services model). Simply, the Non-PCRVU refers 
to all of the non-primary care workload during the year, which could be from one or many visits to outpa-
tient specialty care, and the PCRVU is the primary care workload during the year from outpatient primary 
care. One advantage of using RVUs in our approach as opposed to simple face-to-face visit counts lies in 
its ability to further accommodate workloads generated by telephone encounters at the VHA. It is noted 
that the RVU can be seen as a comparable measure of value for care services used in the US Medicare 
reimbursement and is determined by assigning weight to factors such as personnel time, level of skill, and 
sophistication of equipment required to render patient services. The predictor variables include baseline 
demographic and socioeconomic attributes along with some medical factors such as whether the patient 
has insurance, to which VA facility the patient has been admitted, and so on. Before presenting descrip-
tives of the independent variables we perform some data-preprocessing activities to prevent unexpected 
errors during model fitting phase. These include: 1) discarding and imputing (by unconditional mode im-
putation) missing values of such features as ‘VISN’ and ‘CAN Score’ (will be introduced shortly), 2) re-
moving outliers from such variables as ‘Age’ and ‘Assigned provider experience’ thus focusing on the 
first through ninety-ninth percentiles, and 3) binning multimodal, highly skewed features such as ‘Dis-
tance’ and ‘Length of stay’ into discrete factors. Following this preprocessing, the number of records was 
reduced to 81190 patients.  
To achieve a better picture of the data environment, we tentatively arranged all independent attributes 
into five groups as summarized in Table 1. It should be noted that these variables remain the same for a 
patient during the fiscal year. Note that SD stands for standard deviation and % denotes the percentages of 
the subgroup in the population. ‘Priority’ levels range from 1-8 and are assigned based on the veteran’s 
severity of service-connected disabilities and VA income means test (VHA Handbook 1601A.03). ‘Dis-
tance’ is calculated in miles between patient’s home zip code and the zip code of the facility he/she admit-
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ted, considering the latitude and longitude of the two locations. Records with a calculated distance greater 
than 240 miles were excluded and the remaining were converted into three levels. ‘Changed provider 
count’ denotes the number of times during the year that the patient changed his/her assigned provider. As 
mentioned earlier this variable could be a marker of unbalanced workload among PCPs and discontinuity 
of care received by patients. ‘Length of stay’ (LOS) displays the number of days spent admitted at a VA 
hospital. ‘CAN Score’ is the care assessment need score, which reflects the likelihood of admission or 
death within a specified time period. This score is commonly expressed as a percentile ranging from 0 
(lowest risk) to 99 (highest risk) and it indicates how a VA patient is compared with other patients in 
terms of the likelihood of hospitalization or death. Each PCMH team has a unique 10-digit code through-
out all VA medical systems nationwide. Currently all teams have the same number of professions within 
all VA centers. The number of PCMH teams and VA facilities in our data set are 6,051 and 287 respec-
tively. ACC categories are determined based on the various ICD-9-CM (International Classification of 
Disease, ninth version, Clinical Modification) codes assigned to the patient at each visits during the whole 
fiscal year. They basically indicate the occurrence of a specific disease group, and they are not mutually 
exclusive categories, meaning that a patient may have more than one ACC during the fiscal year and most 
actually do.       
As shown in the table, the mean age of patients is 62.42 years (SD = 15.26) and about half of the co-
hort were over age 63 (median = 63). Not surprisingly, near 94% of our veteran population was male and 
approximately 61% of all were insured. Over half of the patients were married but lower than one third of 
all were reported as actively employed. The most frequently enrolled patients are the low income and 
Medicaid group followed by >50% connected disability, and non-service connected patients with income 
above HUD (Housing and Urban Development). The majority of patients (93%) did not spend a day as an 
inpatient admitted to the hospital, and most of them travelled only a short distance to receive care from 
the VA hospitals. The mean care assessment score is roughly 47 with a great variation (SD = 28.88). Al-
so, on average, most of patient’s assigned providers are well experienced working rather full time in their 
roles.   
Next, we provide two schematic views of the mean annual care demand and disease prevalence of 
multiple patient groups. In Fig.1, the average RVU demands of the primary and non-primary care gener-
ated are displayed across different priority groups with insurance status nested. Not unexpectedly, the 
non-primary care effort is always more than the primary care workload and its ratio changes from 1.8 in 
group 8-insured to 6.6 in group 4-uninsured. In all priority groups, uninsured VA patients compared to 
insured ones produce, on average, more workload in terms of both primary and non-primary care. In addi-
tion, the biggest (lowest) workload demands for both primary and specialty care services are associated 
with group 8-uninsured patients (group 6-insured patients). 
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Fig.2 displays a mosaic plot of illness types along with patients’ gender and their marital status. We 
excluded ACC 28 (neonate’s diseases) and ‘unknown’ marital category from these analyses because of 
either the absence or rarity in our sample study. Note that letters P, N, and M above the marital bar denote 
‘Previously married’, ‘Never married’, and ‘Married’ groups. The ACC labels are given in the Table 6. 
As shown, the most commonly occurring conditions among all patient clusters is ACC 30 (Screening) 
followed by ACCs 5 (nutritional and metabolic) and 16 (heart). However, the least prevalent illnesses 
among the VA patients are ACC24 (pregnancy-related), ACC13 (developmental disability), and ACC15 
(cardio-respiratory arrest). Plus, in almost all disease types, married males are more at risk than two other 
male groups. 
3  Methodology 
In this section we first propose our approach and present its exclusive properties for modeling the PCMH 
demand variations. Then we develop a Bayesian framework with novel prior specifications for parameter 
estimation and model inference. 
3.1  Model Specification 
The PCMH data is hierarchically organized into three nested levels as shown in Fig.3, where patients are 
grouped within PCMH teams, and teams are in turn nested within VA facilities. Note that PCMH teams 
are tied to facilities, i.e., a specific team cannot work at different facilities (teams are nested within facili-
ties). Risk factors can be associated with the response variables at each level while patients from the same 
team (facility) may have more similar outcomes than patients chosen at random from different teams (fa-
cilities). For example, we can study the effects of age (patient-level), PCMH assigned provider’s experi-
ence (team-level), and type of hospital (facility-level) on the outcomes with nested sources of variability. 
This setting, in addition to health services research, may happen in many other applications such as edu-
cational studies where students are nested within schools and successively within school district. It has 
been shown that ignoring a level of hierarchy in a data can greatly influence the estimated variances and 
sensitivity [19], can seriously inflate Type I error rates [20], and also can result in errors in interpreting 
the results of statistical significance tests [21]. As such, multilevel statistical models have been proposed 
to appropriately analyze the hierarchical (correlated) nesting of data, taking into account the variability 
associated with each level of the hierarchy [22].  
To simplify, we begin by creating a univariate 2-level generalized linear model (GLM) that predicts 
the primary care RVU (PCRVU) in each PCMH team with one patient-level (age) and one team-level 
(assigned provider’s experience) predictors. The level-1 model would look like 
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 0 1   i j j j i j i jy e                                                          (1) 
where 
 i jy  is the PC workload for patient i in PCMH team j with an exponential family density of form 
( )
( | , ) ( , )exp
y b
f y x c y
 
 

 
  
 
, 
0 j  is the average PC workload generated in team j,  i j  is 
the patient-level predictor (age) for patient i in team j, and 
1 j  is its coefficient or slope. The parameters 
  and   are called canonical (natural) parameter and scale (dispersion) parameter, respectively. Also 
( )c   and ( )b   are determined by the type of (conditional) distribution under study. This way, we assume 
that each team has a different (varying) intercept coefficient and a different (varying) slope coefficient. 
These team-specific coefficients can be specified as either fixed effects or random effects [23]. Treating 
them as fixed effects, however, leads to a large number of parameters with often very poor estimation re-
sults. A more conservative way is to think of them as random variables being modeled by some (level-2) 
hyperparameters. The last term, 
 i je , is the patient-level error term which is assumed to be normally dis-
tributed with covariance structure R. Unlike most methods in the literature, which suppose that the resid-
ual variation is the same at the 2-level (teams) and/or the upper levels of hierarchy, we allow unequal var-
iations of the residual to be passed not only on various levels of the hierarchy but also on different re-
sponse variables.  
The next step is to explain the variation of the (level-1) regression coefficients introducing explanato-
ry variables at the team level like 
                                                          
0 00 01  
1 10 11 1    .
j j o j
j j j
Z u
Z u
  
  
  
  
                                                   (2) 
In this equation, 00  is the grand mean of PC workload across patients and across PCMH teams, 10  is 
the average effect of the patient-level predictor (age) across all teams,
jZ is the team-level predictor (as-
signed provider’s experience) for team j, 01  and 11  are its (level-2) intercept and slope regression coef-
ficient, and the u -terms are random errors at the team level, which are assumed to be normally distribut-
ed with covariance G. Similar to the R-side covariance matrix, we let these level-2 random errors have 
unequal variances and also leave them free to be correlated with each other. It is worth pointing out that 
jZ  in the second line of (2) acts as a moderator for the relationship between workload and patient age at 
level-1 analysis; that is, the relationship varies according to the value of the moderator variable. Follow-
ing the same logic, we can extend this model to add further hierarchies at the facility-level, at the regional 
level, and so on.   
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Now a multivariate generalization of this hierarchical GLM is proposed in which both PC and 
Non-PC workloads are predicted simultaneously. There are several advantages of using a multivariate 
approach instead of univariate method [24]. One is that the multivariate analysis can better control the 
type I error rate compared to carrying out a series of univariate statistical tests. Second, this approach can 
shrink the prediction interval of the dependent variables to a large extent when compared to predicting 
one of them in isolation. Also using a multivariate scheme, the covariance structure of the responses can 
be decomposed over the separate levels of hierarchy, which can be of much value for multilevel factor 
analysis.  
Suppose we have P response variables and let 
   h i j kY  be the workload on outcome h (PC or Non-PC 
workload here) of patient i in PCMH team j and facility k. Here we put the measures (responses) on the 
lowest level of hierarchy, and represent the different outcome variables by defining P dummy variables 
like  
    
1     
    .
0    
p h i j k
p h
d
p h

 

 
Then we formulate the lowest level as  
   1   1 1   2   2 2          ...    ,h i j k i j k i j k i j k i j k p i j k p p i j kY d d d       
in which neither the usual intercept nor the error term exists as before. The reason for this is that we sole-
ly serve the lowest level as a way to define the multivariate structure using dummy variables. Then fol-
lowing (1), we may use  -terms to employ regression equations at the patient level  
                                                       
    0   1        p i j k p j k p j k p i j k p i j kX e                                    (3) 
in which a separate index is utilized for denoting the dependent variable of interest. It is noted that with 
this approach one can fit different intercepts and slopes for different response variables and allow them to 
vary across any levels of hierarchy. Following (2), at the team level, we can have 
                                                
 0   0 0  0 1   0  
 1   1 0  1 1   1      ,
p j k p k p k j k p j k
p j k p k p k j k p j k
Z u
Z u
  
  
  
  
                                    (4) 
where we introduce our 2-level predictors (level-1 moderators) along with random intercepts and slopes 
and finally link them to the facility level equations by  
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 0 0  0 0 0  0 0 1  0 0 
 0 1  0 1 0  0 1 1  0 1 
 1 0  1 0 0  1 0 1  1 0 
 1 1  1 1 0  1 1 1  1 1       .
p k p p k p k
p k p p k p k
p k p p k p k
p k p p k p k
W u
W u
W u
W u
  
  
  
  
  
  
  
  
                                     (5) 
Keeping on this way, one can straightforwardly extend the model to include more predictors at each level 
and study the effects of fixed and random parameters at any given point. Another advantage of such mod-
eling is that we can impose an equality constraint across all response variables to build a specific relation 
with certain effects. For example, we can force level-1 regression coefficients for p=1 (PC workload) and 
p=2 (Non-PC workload) to be equal by adding the constraint 
1 1  2 1  j k j k  . This makes the new mod-
el nested within the original model, and thus we can test whether simplifying the model is justified, using 
a chi-square test on deviances. Plus, if the predictor has random components attached to it, a similar ap-
proach would apply to the random part of the model.  
At this point, we specify the structure of random components in the model. As shown, we have two 
random parts in our method: first is the level-1 residual errors as appear in (3) by e -terms, and second 
relates to (higher level) varying intercepts and slopes introduced by u -terms in (4) and (5). We denote 
the covariance matrix of the former as R and the latter as G and then assume that both are normally dis-
tributed with 
                                                               
   E
Var      .
   
   
   
   
   
  
u 0
e 0
u G 0
0 Re
                                               (6) 
As illustrated, the residual and random parameters are independent having zero means. Generally G and R 
matrices are large and square with dimensions equal to the number of random coefficients and residuals. 
While several structures such as spatial or compound symmetry can be thought to formulate those, here 
we propose an unstructured parameterization tactic by taking the Kronecker product of their decomposed 
matrices, named Parametric and Structured, as 
                                                    2 2           .
 
  
 
  
1 1
P S 0 0
G 0 P S 0
0 0
                                     (7) 
At the moment we focus on G decomposition, but a same logic is applied to R. In (7),   shows the 
Kronecker (direct) product; P -terms represent the Parametric part, which is low dimension and needs to 
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be estimated by data; S -terms stands for Structured part, which is typically high dimensional and as-
sumed as known; and zero-off diagonals express the independence among components. Note that in its 
simplest case such as general linear models, where the Parametric matrix is reduced to scalars and the 
Structured part is taken as identity matrices, equation (7) will reduce to the previously known formula 
2 G P S = I . Thus we can imply (7) as a generalization for covariance functions of other linear 
statistical models.    
To better describe the structure in (7), we present examples from our case study. Suppose that we are 
interested to know whether the identity of a VA facility introduces dissimilar amounts of workload varia-
tions. Thus we may construct the top left part of (7) like             
                               
,
,
 
 
 
   
 
 
2
PCRVU PCRVU Non-PCRVU
Facility Facility 2
Non-PCRVU PCRVU Non-PCRVU
P S I                (8) 
which permits heterogeneous variances across workloads (main diagonal) along with their possible corre-
lation (off-diagonal), and further postulates that the facilities are independent to each other (with the iden-
tity matrix). So at the worst case for fitting (8), we need 3 degree-of-freedom (DF) to estimate three dif-
ferent elements from the Parametric matrix. Further, we may suspect that it is better to fit age (level-1 
predictor) with varying intercept and slopes presented by different teams as      
                                          
,
,
 
 
 
   
 
 
2
(Intercept) (Intercept) Age
Team Team 2
Age (Intercept) Age
P S I                         (9) 
where the (1:1) element is the amount of variation in regression intercepts among different teams, the 
(2:2) element is the amount of variation in regression slopes introduced by the patient age across teams, 
and as before the identity matrix expresses the independence among PCMH teams. Here the model speci-
fication is completed and in the next part we explain the model fitting and inference in a Bayesian frame-
work. 
3.2  Estimation and Inference   
Before describing model inferences, we give another but equivalent description of our proposal. By sub-
stituting equation (2) into equation (1) and rearranging the terms, we have 
                                      
 00 10  01 11  1    i j i j j i j j j i j o j i jy Z Z u u e                             (10) 
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in which two distinct segments can be implied: the first is 
00 10  01 11  i j j i j jZ Z          , which 
we call the deterministic part, and the second is 
1    j i j o j i ju u e     , which we call the stochastic part. 
That way, the moderator effect of (2) is expressed as cross-level interaction 
 i j jZ  and the multiplication 
1  j i ju  directly reveals that the error is different for different values of  i j  (heteroscedasticity). Taking 
a matrix form, we may rewrite the right-hand-side of (10) as = Xγ +Wεη , where X  and W are the 
design matrices for deterministic and stochastic parts. Then the left-hand-side of (10), conditional on the 
stochastics, shapes a GLM response of  g E   Y ε , where ( )g   is a differentiable monotonic link 
function that allows the outcomes to possess any member of the exponential class of distributions. Now 
assuming a density function of ( ; )p p pq ε for the stochastic part of the pth response variable (
1,2, ,p P  ), we can make inferences about the unknown parameters by maximizing the marginal 
likelihood 
                                        
1
( , , | ) ( | , ) ( ; )     ,
P
p p p p p p p p
p
L f q d    

 γ Y Y ε ε                    (11) 
where 
1 2, , , P   γ γ γ γ  is the vector of deterministic coefficients, ( ; )
p p pq ε  is a multivariate 
Gaussian distribution of dimension  P with mean zero and variance-covariance 
p , and p and 
p  are 
the GLM scale and canonical parameters, respectively.  
Generally two basic methodologies have been expressed in the literature for optimizing a univariate 
version of (11): the first one tries to approximate the model based on linearization and pseudo-data with 
fewer nonlinear components, such as the pseudo-likelihood technique of  Wolfinger, O'connell [25]. The 
second category consists of integral approximation methods that attempt to approximate the log likeli-
hood of (11), such as adaptive Gaussian quadrature [26]. But both approaches have some key drawbacks 
that, we think, cause them inappropriate for our study context. For example, a true objective function for 
the overall optimization does not exist in the first class; thus it potentially produces estimates that are in-
consistent under standard (small domain) asymptotic assumptions. Additionally, the bias size can be sub-
stantial in the case of major variance components or few observations per participant. Similarly, methods 
in the second approach cannot accommodate R-side covariance structure such as overdispersion parame-
ter [27]. These problems also become more crucial when more than one outcome needs to be estimated 
[28].  
Due to this, we decide to put forward a Bayesian framework that utilizes an exact maximum likeli-
hood approach by numerical integration techniques. To this end, we need to first determine suitable priors 
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for the parameters of interest then employ a simulation-based integration technique, such as Metropo-
lis-Hastings or slice sampling, to iteratively sample the posterior until convergence. Afterwards, generat-
ed samples are used to estimate the approximate expectations of quantities of interest. However, setting 
up the appropriate priors can greatly affect inference about posteriors, because in many cases, diffuse pri-
ors and/or improper priors lead to improper posteriors upon which no valid inference can be made [29]. 
Accordingly, for the deterministic coefficient vector 
pγ , we use a Gaussian prior of form  0 ,N γ  . 
Moreover, to sample from η , since its distribution cannot be identified, we apply the Metropo-
lis-Hastings update of Damlen et al. [30]. In summary, the method is updating η  in some blocks; each 
consists of groups of residuals expected to have some form of residual co-variation as defined by the R 
structure. That way, the conditional density of 
pη  is formulated as 
                                       ( | ; , ) ( | ) ( | , )
p p p p p p p
l i i i N l l
i l
f p f

Y γ ε Y e 0 Rη                               (12) 
where l stands for blocks of 
pη with non-zero residual covariances, 
p
Nf  indicates a conditional multivari-
ate normal distribution for the linear predictor residuals, and ( | )
p p
i i ip Y  is the probability of data point 
p
iY (from p
th
 outcome) with linear predictor 
p
lη .  
In order to update the parameter vector 
T T T,p   γ ε , the single-block Gibbs sampler of García-
Cortés, Sorensen [31] is applied. Essentially, the method solves the sparse linear system of 
1 T 1
 (1 )
p p p 
  M R M e    using Cholesky decomposition technique. In the formula,  is the 
coefficient matrix of form 
1
T 1
1



 
   
 
0
M R M
0 G

 , in which = [  ]M X W  is the whole design 
matrix,   is the prior (co)variance matrix for the deterministic part, and    p p , e are random realiza-
tions drawn from multivariate normal distributions 
0
 ~ ,
p N
    
    
    
γ 0
0 0 G


 and 
 ~ ( , )
p pN e M R  respectively. Based on these, the desired prior sample of ( | ; , , )
p pf M R Gη   is 
given by  
p p
  . 
For taking samples of the variance structures R and G , we need the sum of squares matrix associat-
ed with each diagonal component of (7). This is given by 
T 1= H S  , where   is a stochastic matrix 
in which each column is related to the relevant row/column of Parameteric matrix P and each row is as-
sociated with the related row/column of Structured matrix S . In this way, P can be Gibbs sampled in one 
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block from the Inverse-Wishart (IW) distribution
1~ (( ) , )p pIW n n

 P H H , where n  is the 
number of rows in , pH is the prior sum of squares, and pn  is its degrees of freedom. It should be not-
ed that IW is a conjugate prior for the covariance matrix of a multivariate normal distribution. 
Usually the goodness-of-fit of Bayesian models can be assessed using the deviance information crite-
rion (DIC), which is a Bayesian alternative to AIC and Schwarz criterion. The DIC can be calculated at 
different levels of hierarchy and a smaller amount indicates a better fit to the data while compensating for 
model complexity. Here, we adopt the method of Spiegelhalter et al. [32] and define the deviance as 
2log(Pr  ( ) )D   Y | , where   are some parameters of the model. We calculate this probability 
for the lowest level of the hierarchy at each iteration. In the formula, in case of Gaussian responses we 
have , R   and the likelihood would be the normal density ( | , )Nf Y Xγ +Wε R . On the other 
hand, when the responses are not normal,  η  and the likelihood would change to  |p pi i i
i
f Y η , 
where the argument denotes the conditional probability of the i
th
 data point (lowest level of hierarchy). In 
other words, for non-Gaussian responses, deviance is obtained by the probability of the data given the 
linear predictor η , whereas in normal responses, it is calculated using the probability of the data given 
the parameters. The DIC can then be attained by DIC = 2 ( )D D  , where D  is the mean deviance 
of all iterations and ( )D   is the deviance evaluated at the mean estimates of the parameters.    
4  Analytics      
4.1  Model Fitting and Diagnostics 
We conduct multiple analyses to estimate the effect of different patient factors such as disease types 
(ACCs) on the mean annual primary and non-primary care. To employ our method we first determine the 
appropriate distributions for the two responses. Here the standard Quantile-Quantile plot along with max-
imum likelihood method is used, but one can also employ non-parametric techniques such as kernel den-
sity estimation. We examine different base densities such as gamma, lognormal, beta, and Cauchy, then 
judge the best choice as having the best graphical pattern in QQ plot and the biggest likelihood value sim-
ultaneously. Based on these criteria, the lognormal distribution is found the most proper case for both 
RVUs. Fig. 4 shows the QQ plots along with bootstrapped point-wise confidence envelopes at 0.95 accu-
racy rate. As shown, the PCRVU (left panel) displays a perfect linear pattern, and even for Non-PCRVU 
(right panel), almost all points lie within the confidence band. We also get the minimum value of the mi-
nus log-likelihood based on ML fitting when the lognormal distribution is taken. 
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To determine the appropriate link function ( )g  , a range of classical options including log link and 
inverse link are evaluated by two goodness-of-fit measures, namely DIC and modified HL test [33]. 
Based on the results (not shown here) we observe that the (default) identity link does estimate the upper 
and lower tails of both RVUs, accounted for the covariates, more properly than other links, and thus it is 
chosen for our study. 
Since failing to specify the suitable probability density for priors can result in inferential and numeri-
cal problems as discussed in Section 3.2, for the deterministic parameters we pick a multivariate normal 
density with zero vector for the mean
0γ  and a diagonal matrix of large variances (1e+10) for  . This 
way we can make sure that the prior is always proper. However, for each (decomposed) block of the 
G-(R-) side, we are required to specify the hyperparameters through the IW distribution, which takes two 
scalars; the expected (co)variance at the limit and the degree of belief parameter. We configure several 
prior specifications not only for these two parameters but also for different shapes (degrees of freedom) 
the decomposed matrices can take, then assess the impacts on the DIC measure and their posterior distri-
butions (with MCMC diagnostics). A few such comparisons are discussed in Section 4.2, but now for the 
first step of our modeling strategy (discussed later), we choose a diagonal matrix of 1/3 (similar to (8)) for 
all three hierarchies (patients, PCMH teams, and facilities) with 2 degrees of freedom. Scaling outcomes 
to have a unit variance before the analysis, this prior implies that the total variance is equally split across 
all three levels together with a priori independence of PC and Non-PC workloads. 
Although different modeling strategies could be selected for estimating our multilevel model, we fo-
cus on the most parsimonious and best-fitting approach for the given data and our specific research ques-
tions. To this end, six models (Table 2) from basic to comprehensive are run sequentially and the outputs 
are reported for each step in order to provide insights for a particular objective. Further, to avoid overfit-
ting within each step, we perform stepwise selection for the deterministic covariates with probabilities to 
enter and stay of 0.15 and 0.1 respectively. Alternatively, one can employ a Bayesian selection to deter-
mine a variable subset [34]. Different functional forms of covariates, such as logarithmic and power rela-
tions, as well as within-level interactions are evaluated too at each step but only the statistically signifi-
cant ones are included. As an example, we analyze 12 pairs of ACC interactions that are notable for 
co-occurring in patients with multiple chronic illnesses and/or an acute disease combined with a chronic 
condition [35]. 
The improvement in model fit is evaluated by DIC (see Section 3.2) over all iterations after the 
burn-in phase of MCMC simulations. Based on a rule of thumb, we favor the model with lower DIC 
when the DIC reduction of more than 10 units is observed. Depending on the goodness-of-fit and signifi-
cance tests, sometimes intermediate models, such as a reduced version of model 3 with only one signifi-
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cant random slope, are also examined. Performing this strategy, we seek to answer the following three 
research questions: 
 How much of the variance in PC and Non-PC workload is associated with patients, PCMH teams, 
and VA facilities? 
 Does the effect of any patient-level predictor change among PCMH teams or VA facilities? And 
does the effect of any team-level predictor vary among VA facilities? 
 What is the impact of patient non-adherence (as measured by “Changed provider count”) on PC 
workload, controlling for patient, PCMH team, and VA facility characteristics?   
Setting the significance level at 0.05, we run the models with 50,000 iterations, a burn-in period of 
10,000, and a thinning interval of 25. All analyses and computations are done in R version 3.0.2 [36]. In 
order to address the first question, we fit the unconditional model as summarized in Tables 3-5. Note that 
the first (third) row in each table shows PC (Non PC) intercept variance along with its 95% Highest Pos-
terior Density interval, and the second row corresponds to the workload correlations.  The team ICC for 
the PC outcome is computed as 
0.168 
0.609 0.168 0.218  
. Simply put, we find that about 17% of the 
variation in PC workload exists between PCMH teams and 22% is there between VA facilities, leaving 
near 61% of the variance to be accounted for by patients. Thus a practically meaningful proportion of all 
variation happens at higher levels, providing support for our use of a 3-level hierarchical model. These 
percentages are 5%, 16%, and 79% for Non-PC workload respectively. Other useful points can be made 
by interpreting the correlations among PC and Non-PC at different levels. First, the results of a joint con-
ditional independence test Gueorguieva [37] show that the RVUs (at the patient level) are positively asso-
ciated which confirms the fact that a simultaneous modeling of both primary and non-primary care is 
more reasonable than using one of them in isolation. Second, we infer that the correlation is not signifi-
cant when it comes to the team level, and it is poorly significant at the facility level. Hence, we 
re-parameterize structure (8) in a way that the off-diagonal is replaced by zero. By doing so, we save two 
DF, but the changes in variance estimates are too trivial to restate here. 
We continue our modeling effort to include predictors and random components at all levels, and then 
answer other research questions based on the outputs from the best fitting model. For brevity we will not 
walk through all detailed outputs at each stage, and instead summarize them in Table 6. Also note that 
level-2 and level-3 predictors are displayed italic. In each row, the first number is for PC and the second 
is for Non-PC outcome, with (′), (″), () displaying significance at 0.05, <0.001, and non-significance re-
spectively. It worth noting that we suppress the overall intercept since otherwise, the parameter estimates 
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associated with PC are translated as contrasts with Non-PC. Also for team-level, facility-level, and inter-
actions, we only include those factors that are significant in at least one of the six models.  
Graphically assessing the relation of age with the outcomes, we observe that both responses have a 
sigmoidal trend at team levels thus we decide to fit its nested random components with covariance matrix 
like 
2
0 0
0 0
0 0



 
 
   
 
 
  
2
(Intercept)
2
Team Team Age
2
Age
P S I . A similar structure is fitted for CAN Score 
as well, but with square root instead of second power relation. For ‘Changed provide count’ we first test a 
structure with both random intercept and slope at the facility-level, but after failing to reject the null hy-
pothesis of intercept, we reduce it to random slope only. For fitting insurance covariance, again we first 
try 
,
,
 
 
 
 
 
 
Insured Un-insured
2
Insured
2
Un-insured Insured Un-insured
, and then drop the correlation after the significance test.  
According to the DIC index shown at the bottom of Table 6, we realize that each forward model ex-
hibits a better fit to the data, so we take model 6 to answer the remaining research questions. In order to 
further validate the final model, we apply model 6 to FY12 quarter 3 data and find almost identical re-
sults. We repeat the joint independence test of Gueorguieva [37] for model 6 and reaffirm the positive 
correlation of responses at the patient level. Put differently, we find that after controlling for all sources of 
variation, if the primary care workload is increased from one patient to another, on average we will expect 
an increase in the related non-primary care. In the table, the estimates for deterministic effects are inter-
preted as prevalence ratios but variance components are reported in natural scale. Also note that the data 
is scaled to have a unit variance before analysis. 
It is worth to highlight that some estimates are changed in terms of significance among models. For 
example, age, insurance, and CAN Score are significant in Model 2 but no longer significant in later 
models once their related random slopes are introduced in Model 3. Examining other random components 
in these models, we figure out that significant variability exists in their nested random intercepts and 
slopes, even after controlling for these patient-level predictors. Hence, we can say that the association 
between these variables and the outcomes varies considerably among PCMH teams. Thus we expect that 
the influence of patient oldness on care demands may be stronger or weaker from one PCMH team to an-
other within a VA facility. The same thing happens in terms of effect magnitude for ‘Changed provider 
count’ between Models 4 and 5; the relationship between this variable and both workloads changes mean-
ingfully among different VA facilities. By these statements, we tackle our second research question.            
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To answer the last research question, we look at the deterministic effect of ‘Changed provider count’ 
in Model 6. As shown, for each time that a patient switches assigned provider, we will expect an average 
of 6% more workload in his/her primary care, after accounting for variations of his/her non-primary care 
demands. Other selected key findings from Model 6 can be summarized as below:    
 Adjusting for the contributions of all other variables, female VA patients tend for produce about 
57% more PC (98% more Non-PC) compared to males. This is not unexpected due to gender im-
balance issue existed in VA patients. 
 Inpatient cohort generally creates 28% more workload in non-primary care compared to outpa-
tients, after accounting for variations of their primary cares. 
 Catastrophically ill veterans (P4) have 1.15 times the Non-PC demands of the P8 comparison 
group. The increase rates are about 35% and 23% for veterans exposed to Agent Orange (or other 
herbicides) and >50% for disabled veterans. Having been exposed to such chemicals also notably 
affects the increased caress for cardio-respiratory arrest.   
 Change rates in primary cares range from 7% decrease for ACC29 (Transplant) to 52% increase for 
ACC4 (Diabetes). For non-primary cares, this varies from 11% reduction for ACC11 (Substance 
Abuse) to 99% rise for ACC30 (Screening). 
 Both team-level (patient non-adherence) and facility-level (distance) predictors are significantly as-
sociated with the outcomes: Patients travelling more miles to VA hospitals are likely to generate a 
larger amount of care than closely located patients. 
 In co-occurring diseases studies, diabetes greatly interacts with some acute and chronic conditions. 
For instance, in patients with cardio-respiratory arrest, having diabetes is associated with a 13% 
(14%) increase in primary care (Non-PC) workload. Another comorbid condition that poses a simi-
lar pattern is heart disease, especially for cerebrovascular patients. 
 Risk adjustment for disease types and their interactions improves the model fit to a great extent 
(about 160K reduction in DIC) and makes most of their related effects statistically significant.  
Now we present some diagnostic tests for verifying the accuracy of Model 6. First, to assess the Mar-
kov chain convergence and mixing properties, trace plots and smoothed posterior densities are provided 
for each parameter of interest. As an illustration, Fig.5 shows the plots for age and gender across both 
outcomes and Fig.6 displays them for R-side covariance components. As depicted in Fig.5, the traces are 
trendless and the chains are mixing well travelling quickly to the target distribution with small autocorre-
lations.        
Nearly same patterns are observed in Fig.6, but chains are now mixing marginally at a bit slower 
traverse rate, which can easily be tackled by increasing the MCMC iterations. Nonetheless, the densities 
do smoothly estimate the mean posterior for residual variances as reported in Table 6. For deterministic 
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terms in Fig.5, however, the posterior histogram is plotted in log scale. We additionally perform Gelman, 
Rubin [38] and effective sample size tests to all posterior estimates (not shown here) and no violations are 
found therein. 
After additional validation steps such as Copas [39] test of overfitting and posterior correlation diag-
nostics of estimated parameters, we develop two operational indices, namely, hospital level normalized 
intensity score (NIS) and hospital level risk-standardized utilization rate (RSUR) as 
Sum of the total predicted workload of all patients at the given facility
=
Number of patients in the facility  Median predicted workload
jNIS

 
and  
Sum of the total predicted workload of all patients with random components
=
Sum of the total predicted workload of all patients without random components
   .jRSUR  
 
The NIS can be used to adjust the panel size up or down for a given hospital, or even for a specific 
PCMH team within a hospital. Note that the random components are implicitly included in the formula. 
On the other hand, RSUR indicates the ratio of predicted (technically called shrinkage estimate) to ex-
pected utilization; the numerator computes the PC/Non-PC workload when patients are treated as the spe-
cific hospital and denominator calculates the workload as if patients are treated at a so called ‘reference’ 
(or normal) hospital. Thus values greater than one reveals that the hospital is over-utilized as compared 
with the national average range.  
4.2  Numerical Comparisons 
In this section we design three comparison studies to demonstrate some novel aspects of our proposal. 
First, we evaluate an alternative variance structure with the one applied in Model 6 in terms of the good-
ness-of-fit measure. Particularly, for patient (residual), team, and facility random intercepts in scenario 
(1), we change the Parametric matrix to have the same diagonal elements with zero off-diagonals then 
compare the results with the structure used in Model 6. We run each model twice to take control of the 
Monte Carlo error and keep all other factors constant among different fittings. As shown in Table 7, the 
best fit is corresponding to the first row in which the proposed variance structure is applied at all levels of 
hierarchy. 
Second, we investigate the impacts of the random component’s prior specification on MCMC diag-
nostics and posterior distributions. To this end, the DF is kept fixed, and then two alternatives for the ex-
pected limit (co)variance { 1.One 2.REML estimate of Wolfinger, O'connell [25]} , as well as other val-
ues for the IW degree of belief { 0.002, 0.02, 0.2, and 1} are assessed. The values used in Model 6 for 
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these two are 1/3 and zero. Results (available from authors) denote that almost no change occurs in de-
terministic estimates, DIC measure, and directions of (co)variance components. However, the absolute 
range of alternations in variance estimates is around 2.3% that the base values in Model 6. We detect that 
better chain convergence and mixing property is observed when using priors with smaller limit 
(co)variances and larger (near one) degree of the belief parameter. Further, the posterior correlation esti-
mates remain reasonably unchanged while examining different types of priors, which provide some reas-
surance that our priors do not dominate the model to an unacceptable extent. 
Lastly, we perform comparisons between our proposal and the situations when one employs a series 
of univariate (multilevel) GLMs for predicting the outcomes. To this end, we keep Model 6 settings con-
stant and consider two scenarios: 1) A bivariate 3-level GLM with joint primary and non-primary care 
workloads, and 2) Two univariate 3-level GLMs one for primary care (PC) and one for non-primary care 
(Non-PC) workload predictions. Fitting both models, we aggregate the credible intervals for the mean 
outcomes and then compare them with the actual values. Interestingly, the probability of joint correct pre-
diction (for both responses) is about 67% for the first scenario and about 58% for the second. Then we 
pick those correct intervals, compute their ranges { max–min} , and calculate basic statistics for the rang-
es in Table 8. As displayed, the credible intervals are substantially narrowed when applying the multivari-
ate approach. Thus we can conclude that a joint modeling of primary and non-primary care workloads 
would provide more robust and realistic predictions for medical home practices.       
5  Discussion 
A key factor in the success of medical homes in delivering quality and coordinated care lies in their 
teams’ ability to handle uncertainties that can be caused by different sources such as patient/physician 
appointment scheduling, care logistics, and more importantly patients’ health demands. This paper ad-
dresses the problem of clinical demand prediction in the presence of nested sources of variation at differ-
ent operational levels. We collected outpatient visit data from a large sample of Veterans Affairs hospitals 
and investigated the relationship between risk factors at three operational levels and total care demands on 
a yearly basis. We propose a multivariate multilevel generalized linear model in a Bayesian framework to 
predict the care demand portfolio in medical home practices. The proposal can fit heteroscedastic vari-
ances and unstructured covariance matrices for nested random effects and residuals as well as their inter-
actions with categorical and continuous covariates simultaneously.  
We find that utilizing a multilevel analysis with nested random components can greatly contribute to 
model fit in hierarchical healthcare systems. Further, we show that risk-adjustment for patient disease 
conditions and their comorbidities extensively enhances the prediction power of our model. Our results 
confirm that using a multivariate as opposed to a univariate approach can significantly shrink the correct 
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credible intervals for workload predictions thus allowing for a more precise estimation of either outcome. 
The approach used in this paper has a general application and could also be employed for analysis of mul-
tiple health outcomes in a variety of health analytics contexts.    
Turning to specific results from recent VA data, we see that overall, the primary care is positively as-
sociated with the non-primary care (correlation coefficient of 0.027 as appeared in Fig.6) after accounting 
for all studied sources of variability. We find the association between patient-level predictors such as age 
and the care workloads varies considerably among PCMH teams within a hospital. Further, the effect of 
patient non-adherence on care demands is subject to change from one hospital to another. Moreover, it is 
found that patient oldness can contribute to the increased care demands required for heart, nutritional, and 
gastrointestinal diseases.    
Finally there are some limitations to this research that need to be mentioned. First, the data in our 
study are collected solely from a veteran population (with fewer female and more senior patients) who 
receives support from government budgets. Thus the results from our study may not fully generalize to 
other health care systems. Second the data used is administrative and not real time, so some issues such as 
model tuning and calibration should be taken into account when dealing with online prediction efforts.    
Our work can further be extended in some fronts. One challenging direction would be to modify the 
proposed approach to handle longitudinal observations from past history of care demands for a specific 
patient profile. This may be done by expanding the multivariate distribution of outcomes to include a 
temporal dimension which requires great care in model specification and implementations thanks to vari-
ous inter-correlations. Alternatively, one can combine some autoregressive terms to the variance structure 
introduced in this work. Another issue worth exploring is related to the way that one can adjust for patient 
risk or comorbidities. Although several algorithms such as Clinical Risk Group (CRG), veriskhealth 
DxCG, and CMS’s HCC software have been used in the literature, no scientific study is available to sys-
tematically evaluate the impacts of each algorithm on prediction modeling of care demands.   
 
References 
 
1. Green LV, Savin S, Murray M (2007) Providing timely access to care: what is the right patient panel 
size? Joint Commission journal on quality and patient safety / Joint Commission Resources 33 (4):211-
218 
2. Murray M, Davies M, Boushon B (2007) Panel size: answers to physicians' frequently asked questions. 
Family practice management 14 (10):29-32 
3. Ostbye T, Yarnall KS, Krause KM, Pollak KI, Gradison M, Michener JL (2005) Is there time for 
management of patients with chronic diseases in primary care? Annals of family medicine 3 (3):209-214. 
doi:10.1370/afm.310 
 22 
4. Naessens JM, Stroebel RJ, Finnie DM, Shah ND, Wagie AE, Litchy WJ, Killinger PJ, O'Byrne TJ, 
Wood DL, Nesse RE (2011) Effect of multiple chronic conditions among working-age adults. The 
American journal of managed care 17 (2):118-122 
5. Potts B, Adams R, Spadin M (2011) Sustaining primary care practice: a model to calculate disease 
burden and adjust panel size. The Permanente journal 15 (1):53-56 
6. Balasubramanian H, Banerjee R, Denton B, Naessens J, Stahl J (2010) Improving clinical access and 
continuity through physician panel redesign. Journal of general internal medicine 25 (10):1109-1115. 
doi:10.1007/s11606-010-1417-7 
7. Rittenhouse DR, Shortell SM, Fisher ES (2009) Primary care and accountable care--two essential 
elements of delivery-system reform. The New England journal of medicine 361 (24):2301-2303. 
doi:10.1056/NEJMp0909327 
8. Patient-Centered Primary Care Collaborative (PCPCC).  (2009). http://www.pcpcc.org/about/medical-
home. Accessed August 14 2013 
9. Backer LA (2009) Building the case for the patient-centered medical home. Family practice 
management 16 (1):14-18 
10. Fisher ES (2008) Building a medical neighborhood for the medical home. The New England journal 
of medicine 359 (12):1202-1205. doi:10.1056/NEJMp0806233 
11. Beal AC, Fund C (2007) Closing the Divide: How Medical Homes Promotes Equity in Health Care. 
Commonwealth Fund,  
12. Rittenhouse DR, Shortell SM (2009) The patient-centered medical home: will it stand the test of 
health reform? JAMA : the journal of the American Medical Association 301 (19):2038-2040. 
doi:10.1001/jama.2009.691 
13. Reid RJ, Coleman K, Johnson EA, Fishman PA, Hsu C, Soman MP, Trescott CE, Erikson M, Larson 
EB (2010) The Group Health medical home at year two: cost savings, higher patient satisfaction, and less 
burnout for providers. Health affairs 29 (5):835-843. doi:10.1377/hlthaff.2010.0158 
14. Bates DW, Bitton A (2010) The future of health information technology in the patient-centered 
medical home. Health affairs 29 (4):614-621 
15. Shams I, Ajorlou S, Yang K (2014) A predictive analytics approach to reducing avoidable hospital 
readmission. arXiv preprint arXiv:14025991 
16. Bitton A, Martin C, Landon BE (2010) A nationwide survey of patient centered medical home 
demonstration projects. Journal of general internal medicine 25 (6):584-592. doi:10.1007/s11606-010-
1262-8 
17. Klein S (2011) The Veterans Health Administration: Implementing Patient-Centered Medical Homes 
in the Nation's Largest Integrated Delivery System. Commonwealth Fund,  
18. Liu CF, Sales AE, Sharp ND, Fishman P, Sloan KL, Todd-Stenberg J, Nichol WP, Rosen AK, 
Loveland S (2003) Case-mix adjusting performance measures in a veteran population: pharmacy- and 
diagnosis-based approaches. Health services research 38 (5):1319-1337 
 23 
19. Hox JJ (2010) Multilevel analysis : techniques and applications. Quantitative methodology series, 2nd 
edn. Routledge, New York 
20. Moerbeek M (2004) The consequence of ignoring a level of nesting in multilevel analysis. 
Multivariate Behavioral Research 39 (1):129-149 
21. Goldstein H (2011) Multilevel statistical models. Wiley series in probability and statistics, 4th edn. 
Wiley, Chichester, West Sussex 
22. Snijders TAB, Bosker RJ (2012) Multilevel analysis : an introduction to basic and advanced 
multilevel modeling. 2nd edn. Sage, Los Angeles 
23. Demidenko E (2013) Mixed models : theory and applications with R. Wiley series in probability and 
statistics, vol 893, 2nd edn.,  
24. Tabachnick BG, Fidell LS (2013) Using multivariate statistics. 6th edn. Pearson Education, Boston 
25. Wolfinger R, O'connell M (1993) Generalized linear mixed models a pseudo-likelihood approach. 
Journal of statistical Computation and Simulation 48 (3-4):233-243 
26. Pinheiro JC, Bates DM (1995) Approximations to the log-likelihood function in the nonlinear mixed-
effects model. Journal of Computational and Graphical Statistics 4 (1):12-35 
27. Dey D, Ghosh SK, Mallick BK (2000) Generalized linear models: A Bayesian perspective, vol 5. 
CRC Press,  
28. McCulloch CE, Searle SR, Neuhaus JM (2008) Generalized, linear, and mixed models. Wiley series 
in probability and statistics, 2nd edn. Wiley, Hoboken, N.J. 
29. Gamerman D, Lopes HF (2006) Markov chain Monte Carlo: stochastic simulation for Bayesian 
inference, vol 68. CRC Press,  
30. Damlen P, Wakefield J, Walker S (1999) Gibbs sampling for Bayesian non‐conjugate and hierarchical 
models by using auxiliary variables. Journal of the Royal Statistical Society: Series B (Statistical 
Methodology) 61 (2):331-344 
31. García-Cortés LA, Sorensen D (2001) Alternative implementations of Monte Carlo EM algorithms for 
likelihood inferences. Genetics Selection Evolution 33 (4):443 
32. Spiegelhalter DJ, Best NG, Carlin BP, Van Der Linde A (2002) Bayesian measures of model 
complexity and fit. Journal of the Royal Statistical Society: Series B (Statistical Methodology) 64 
(4):583-639 
33. Hosmer Jr DW, Lemeshow S, Sturdivant RX (2013) Applied logistic regression. Wiley. com,  
34. George EI, McCulloch RE (1997) Approaches for Bayesian variable selection. Statistica sinica 7 
(2):339-373 
35. Petersen LA, Byrne MM, Daw CN, Hasche J, Reis B, Pietz K (2010) Relationship between Clinical 
Conditions and Use of Veterans Affairs Health Care among Medicare‐Enrolled Veterans. Health services 
research 45 (3):762-791 
 24 
36. RDC Team (2005) R: A language and environment for statistical computing. R Foundation for 
Statistical Computing. Vienna, Austria, 2013. http://www.R-project.org,  
37. Gueorguieva R (2001) A multivariate generalized linear mixed model for joint modelling of clustered 
outcomes in the exponential family. Statistical Modelling 1 (3):177-193 
38. Gelman A, Rubin DB (1992) Inference from iterative simulation using multiple sequences. Statistical 
science:457-472 
39. Copas JB (1983) Regression, prediction and shrinkage. Journal of the Royal Statistical Society Series 
B (Methodological):311-354 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
10
20
30
40
50
60
70
Y
es N
o
Y
es N
o
Y
es N
o
Y
es N
o
Y
es N
o
Y
es N
o
Y
es N
o
Y
es N
o
P1 P2 P3 P4 P5 P6 P7 P8
NonPCRVU
PCRVU
Fig.1: Average annual RVU demands across patient priority and insurance status 
Fig.2: Mosaic plot of disease prevalence across patient gender and marital status 
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Fig.4: QQ Plots of PCRVU (left) and Non-PCRVU (right) with 95% confidence bands 
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Group Attribute Mean (SD) n (%) 
Demographic Gender 
Male 
Female 
  
76247 (93.91) 
  4943 (6.09) 
Age (as of 7/1/2011, years) 62.42 (15.23)  
Marital status 
Married 
Previously married 
Never married 
Unknown 
  
46634 (57.44) 
22520 (27.74) 
11559 (14.24) 
    477 (0.58) 
Socioeconomic Insurance (of any types) 
Yes 
No 
  
49551 (61.03) 
31639 (38.97) 
Employment status 
Active Military Service 
Employed Full-Time 
Employed Part-Time 
Not Employed 
Retired 
Self Employed 
Unknown 
  
    134 (0.16) 
17008 (20.95) 
  4013 (4.94) 
28619 (35.25) 
28517 (35.12) 
  2039 (2.51) 
    860 (1.07) 
Enrollment Priority 
1 (service connected disability > 50%) 
2 (service connected disability 30%–40%) 
3 (service connected disability 20–30%) 
4 (catastrophically disabled) 
5 (low income or Medicaid) 
6 (Agent Orange or Gulf War illness) 
7 (non-service connected, income below HUD) 
8 (non-service connected, income above HUD) 
  
18404 (22.67) 
  6548 (8.07) 
  9859 (12.14) 
  2285 (2.82) 
21258 (26.18) 
  3697 (4.55) 
  2243 (2.76) 
16896 (20.81) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Baseline characteristics of patient factors (n = 81190) 
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Group Attribute Mean (SD) n (%) 
Utilization VISN 
1 (New England Health Care System) 
2 (Network Upstate New York) 
… 
  
3371 (4.15) 
1846 (2.27) 
Facility 
662 (San Francisco) 
537 (Chicago) 
… 
  
109 (0.13) 
235 (0.29) 
Distance 
Near (Below 25 miles) 
Middle (Between 25 and 50 miles) 
Far (Above 50 miles) 
  
61430 (75.66) 
12344 (15.21) 
 7416 (9.13) 
PCMH team 
1000001805 
… 
  
13 (0.02) 
Assigned provider position 
Primary care physician 
Assistant physician 
Attending physician 
Nurse practitioner 
  
55470 (68.32) 
  5174 (6.37) 
  7365 (9.07) 
13181 (16.24) 
Assigned provider experience (years) 8.40 (7.77)  
Changed provider count 0.74 (0.89)  
Provider full time equivalent 0.86 (0.24)  
Length of stay (inpatient-day) 
Zero 
Non-zero 
  
75522 (93.02) 
  5668 (6.98) 
Clinical CAN Score 47.32 (28.87)  
 
ACC 
1 (infectious and parasitic) 
2 (malignant neoplasm) 
… 
  
9181 (11.31) 
7940 (9.78) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1— continued: Baseline characteristics of patient factors (n = 81190) 
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Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 
No predictors, 
just residual 
and random 
intercepts (Un-
conditional) 
Model 1 + pa-
tient-level pre-
dictors 
Model 2 + ran-
dom slopes for 
patient-level 
predictors 
Model 3 + 
team-level pre-
dictors 
Model 4 + ran-
dom slopes for 
team-level pre-
dictors 
Model 5 + fa-
cility-level 
predictors 
Results used to 
compute Inter-
class Correla-
tion Coefficient 
(ICC) which 
assesses the 
degree of clus-
tering among 
subsets of cases 
in the data.  
Results show 
the relation-
ships between 
patient-level 
predictors and 
outcomes 
Model 2 results 
+ findings that 
show if the 
associations 
between pa-
tient-level pre-
dictors and the 
outcomes vary 
across 
team-level and 
facility- level 
units   
Model 3 results 
+ results that 
reveal the rela-
tionships be-
tween 
team-level pre-
dictors and the 
outcomes  
Model 4 results 
+ findings that 
shows if the 
associations 
between 
team-level pre-
dictors and the 
outcomes vary 
across facili-
ty-level units      
Model 5 results 
+ results that 
indicate the 
relationships 
between 
team-level pre-
dictors and the 
outcomes.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Regression modeling strategy and specific results for 3-level hierarchical model 
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Components Posterior Mean L-95% HPD U-95% HPD 
PCRVU, PCRVU 0.218 0.215 0.220 
PCRVU, Non-PCRVU − 0.006 − 0.009 − 0.002 
Non-PCRVU, Non-PCRVU 0.157 0.153 0.162 
Components Posterior Mean L-95% HPD U-95% HPD 
PCRVU, PCRVU 0.168   0.158  0.176  
PCRVU, Non-PCRVU 0.035  − 0.014  0.059 
Non-PCRVU, Non-PCRVU 0.053  0.049 0.057  
Components Posterior Mean L-95% HPD U-95% HPD 
PCRVU, PCRVU 0.609 0.604 0.614 
PCRVU, Non-PCRVU 0.316 0.298 0.330  
Non-PCRVU, Non-PCRVU 0.787  0781  0.792  
Table 3: Estimated random intercept (co)variances introduced by VA facilities 
Table 4: Estimated random intercept (co)variances introduced by PCMH teams  
Table 5: Estimated patient-level residual (co)variances 
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 Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 
Deterministic Effect       
Gender, Male  0.41″, 0.02″ 0.43″, 0.03″ 0.42″, 0.01″  0.42″, 0.02″  0.43″, 0.02″  
Age  1.02″, 1.04″  1.03, 1.03 1.03, 1.03 1.01, 1.02 1.02, 1.04 
Age   Age  0.92″, 0.94″ 0.9′, 0.91′ 0.91′, 0.93′ 0.92′, 0.94′ 0.92′, 0.93′ 
Insurance, Yes  0.95′, 0.92 0.94′, 0.9 0.95′, 0.91 0.93′, 0.9 0.93′, 0.92 
LOS, Zero  1.07, 0.74″ 1.06, 0.71″ 1.08, 0.73″ 1.07, 0.72″ 1.07, 0.72″ 
CAN Score  1.12″, 1.07″ 1.08, 1.02  1.09, 1.03 1.08, 1.03 1.1, 1.02 
SQRT (CAN Score)  1.15′, 1.19″ 1.1′, 1.12′ 1.12′, 1.13′ 1.11′, 1.12′ 1.12′, 1.13′ 
Priority (ref = 8) 
1 (disability > 50%) 
2 (disability 30%–40%) 
3 (disability 20–30%) 
4 (catastrophically dis.) 
5 (Medicaid) 
6 (Agent Orange, …) 
7 (below HUD) 
 
 
 
0.96″, 1.25″ 
1.02′, 1.32″ 
0.94′, 1.01″ 
1.03″, 1.17″ 
1.05″, 1.03″ 
1.06″, 1.34′ 
1.09″, 1.1″ 
 
0.97″, 1.22″ 
1.02′, 1.28′ 
0.92′, 1.04″ 
1.04″, 1.14″ 
1.04″, 1.05″ 
1.03″, 1.32″ 
1.08″, 1.07″ 
 
0.96″, 1.23″ 
1.03′, 1.29′ 
0.92′, 1.03″ 
1.03′, 1.15″ 
1.05″, 1.04″ 
1.03″, 1.33″ 
1.09″, 1.07″ 
 
0.95″, 1.24″ 
1.01′, 1.3′ 
0.93′, 1.04″ 
1.05′, 1.15″ 
1.05″, 1.03″ 
1.04″, 1.35″ 
1.08″, 1.09″ 
 
0.95″, 1.23″ 
1.01′, 1.28′ 
0.94′, 1.04″ 
1.04′, 1.15″ 
1.05″, 1.04″ 
1.05″, 1.35″ 
1.08″, 1.1″ 
ACC001–Infectious and Par-
asitic 
 1.07″, 1.22″ 1.05″, 1.23″ 1.04″, 1.24″  1.04″, 1.22″  1.05″, 1.22″  
ACC002–Malignant Neo-
plasm 
 1.04″, 1.33″ 1.04″, 1.3″ 1.03″, 1.31″ 1.04″, 1.32″ 1.03″, 1.31″ 
ACC003–Benign/In 
Situ/Uncertain Neoplasm 
 1.07″, 1.65″ 1.06″, 1.65″ 1.06″, 1.64″ 1.07″, 1.64″ 1.06″, 1.64″ 
ACC004–Diabetes  1.53″, 0.98′ 1.52″, 0.97′ 1.53″, 0.96′ 1.53″, 0.97′ 1.52″, 0.98′ 
ACC005–Nutritional and 
Metabolic 
 1.18″, 1.02 1.19″, 1.03 1.2″, 1.02 1.2″, 1.04 1.19″, 1.03 
ACC006–Liver  1.13″, 1.04′ 1.11″, 1.05′ 1.12″, 1.05′ 1.11″, 1.05′ 1.11″, 1.04′ 
ACC007–Gastrointestinal  1.09″, 1.13″ 1.07″, 1.14″ 1.07″, 1.14″ 1.08″, 1.15″ 1.08″, 1.14″ 
ACC008–Musculoskeletal 
and Connective Tissue 
 1.18″, 1.27″ 1.17″, 1.27″ 1.16″, 1.28″ 1.16″, 1.27″ 1.17″, 1.26″ 
ACC009–Hematological  1.09″, 1.05″ 1.08″, 1.06″  1.07″, 1.06″  1.08″, 1.04″  1.08″, 1.05″  
ACC010–Cognitive Disor-
ders 
 1, 1.12″ 0.98, 1.1″ 1, 1.11″ 0.99, 1.12″ 1.1, 1.12″ 
ACC011–Substance Abuse  1.06″, 0.88″ 1.06″, 0.9″ 1.05″, 0.9″ 1.05″, 0.89″ 1.06″, 0.89″ 
Table 6: Coefficient estimates from 3-level hierarchical model for joint PC and Non-PC workloads 
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 Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 
ACC012–Mental  1.03′, 1.73″ 1.04′, 1.7″ 1.03′, 1.71″ 1.04′, 1.71″ 1.04′, 1.73″ 
ACC013–Developmental 
Disability 
 0.99, 1.24″ 1.01, 1.23″ 1.01, 1.22″ 1, 1.22″ 1.01, 1.24″ 
ACC014–Neurological  1.07″, 1.15″ 1.06″, 1.14″ 1.07″, 1.16″ 1.07″, 1.15″ 1.07″, 1.14″ 
ACC015−Cardio-Respiratory 
Arrest 
 1.07′, 1.02 1.03′, 1.04 1.05′, 1.03 1.05′, 1.03 1.06′, 1.03 
ACC016−Heart  1.15″, 1.05′ 1.14″, 1.06′ 1.16″, 1.04′ 1.15″, 1.05′ 1.15″, 1.05′ 
ACC017−Cerebrovascular  1.05, 1.02 1.05, 1.03 1.04, 1.01 1.03, 0.99 1.04, 1.01 
ACC018−Vascular  1.08″, 1.26″ 1.1″, 1.26″ 1.09″, 1.27″ 1.11″, 1.27″ 1.09″, 1.26″ 
ACC019−Lung  1.09″, 1.11″ 1.07″, 1.12″ 1.08″, 1.12″ 1.08″, 1.11″ 1.08″, 1.1″ 
ACC020−Eyes  1.08″, 1.12″ 1.09″, 1.13″ 1.09″, 1.14″ 1.07″, 1.13″ 1.07″, 1.11″ 
ACC021−Ears, Nose, and 
Throat 
 1.11″, 1.40″ 1.12″, 1.38″ 1.1″, 1.39″ 1.12″, 1.39″ 1.11″, 1.39″ 
ACC022−Urinary System  1.06″, 1.01 1.07″, 1.02 1.08″, 1.02 1.08″, 1.01 1.07″, 1.01 
ACC023−Genital System  1.09″, 1.07″ 1.09″, 1.04″ 1.1″, 1.06″ 1.11″, 1.05″ 1.11″, 1.06″ 
ACC025−Skin and Subcuta-
neous 
 1.11″, 1.42″ 1.13″, 1.43″ 1.12″, 1.43″ 1.13″, 1.41″ 1.12″, 1.41″ 
ACC026−Injury, Poisoning, 
Complications 
 1.1″, 1.28″ 1.11″, 1.29″ 1.12″, 1.3″ 1.12″, 1.29″ 1.12″, 1.29″ 
ACC027−Symptoms, Signs, 
and Ill-Defined Conditions 
 1.17″, 1.45″ 1.15″, 1.41″ 1.16″, 1.42″ 1.17″, 1.44″ 1.16″, 1.43″ 
ACC029−Transplants, Open-
ings, Amputations 
 0.9″, 1.01 0.94″, 0.98 0.92″, 0.99 0.93″, 1 0.93″, 1.01 
ACC030−Screening/History  1.22″, 2.01″ 1.23″, 1.98″ 1.2″, 1.98″ 1.2″, 2″ 1.22″, 1.99″ 
Changed provider count    1.11″, 1.09″ 1.04′, 1.03′ 1.03′, 1.02′ 
Distance (ref = Far) 
Middle 
Near 
 
 
    
 
 
0.89″, 0.87′ 
0.85″, 0.93′ 
Diabetes   Liver  1.02, 1.13′ 1.03, 1.15′ 1.03, 1.16′ 1.01, 1.16′ 1.01, 1.14′ 
Diabetes   Car-
dio-Respiratory Arrest 
 1.12′, 1.11″ 1.1′, 1.13″ 1.13′, 1.12″ 1.15′, 1.14″ 1.13′, 1.14″ 
Diabetes   Heart  1.03, 1.1″ 1.04, 1.12″ 1.03, 1.11″ 1.01, 1.11″ 1.01, 1.11″ 
Diabetes   Cerebrovascular  1.07′, 1.17′ 1.06′, 1.14′ 1.06′, 1.15′ 1.06′, 1.16′ 1.06′, 1.15′ 
Diabetes   Urinary System  1.04, 1.12′ 1.06, 1.1′ 1.05, 1.1′ 1.07, 1.13′ 1.06, 1.13′ 
Table 6—continued: Coefficient estimates from 3-level hierarchical model for joint PC and Non-PC workloads 
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 Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 
Diabetes   Transplants, 
Openings, Amputations 
 1.08′, 1.09 1.09′, 1.07 1.09′, 1.08 1.11′, 1.09 1.1′, 1.09 
Substance Abuse   Mental  1.04″, 1.20″ 1.03″, 1.21″ 1.04″, 1.21″ 1.05″, 1.22″ 1.04″, 1.21″ 
Heart   Cerebrovascular  1.12′, 1.14″ 1.09′, 1.13″ 1.1′, 1.15″ 1.11′, 1.16″ 1.11′, 1.16″ 
Heart   Vascular  1.06, 1.04′ 1.07, 1.05′ 1.05, 1.05′ 1.05, 1.06′ 1.04, 1.06′ 
Cerebrovascular   Vascular   1.01, 1.12″ 1.03, 1.13″ 1.02, 1.14″ 1.03, 1.14″ 1.03, 1.12″ 
Male   Diabetes  1.06′, 1.12′ 1.05′, 1.14′ 1.04′, 1.14′ 1.07′, 1.11′ 1.05′, 1.13′ 
Male   Neurological  1.08″, 1.11′ 1.09″, 1.13′ 1.1″, 1.12′ 1.13″, 1.12′ 1.1″, 1.12′ 
Age   Heart  1.11″, 1.21′ 1.09″, 1.19′ 1.09″, 1.2′ 1.08″, 1.22′ 1.08″, 1.2′ 
Age   Nutritional and Meta-
bolic 
 1.14′, 1.07″ 1.15′, 1.09″ 1.14′, 1.08″ 1.14′, 1.1″ 1.16′, 1.09″ 
Age   Gastrointestinal  1.05′, 1.1′ 1.07′, 1.12′ 1.06′, 1.12′ 1.08′, 1.09′ 1.08′, 1.1′ 
Priority 4   Neurological  1.13′, 1.17″ 1.14′, 1.17″ 1.11′, 1.16″ 1.15′, 1.16″ 1.14′, 1.16″ 
Priority 6   Car-
dio-Respiratory Arrest 
 1.14″, 1.06′ 1.14″, 1.07′ 1.13″, 1.07′ 1.11″, 1.09′ 1.11″, 1.07′ 
Variance Component        
Residual  0.609′, 0.79′  0.446′, 0.55′ 0.357′, 0.46′ 0.352′, 0.44′ 0.259′, 0.43′ 0.255′, 0.43′ 
Intercept (team) 0.168′, 0.05′ 0.093′, 0.04′ 0.076′, 0.04′ 0.064′, 0.04′ 0.059′, 0.03′ 0.054′, 0.03′ 
Intercept (facility) 0.218′, 0.16′ 0.125′, 0.1′ 0.106′, 0.08′ 0.091′, 0.08′ 0.085′, 0.07′ 0.083′, 0.05′ 
Slope (age: team)   0.088′, 0.09′ 0.081′, 0.09′ 0.075′, 0.1′ 0.073′, 0.08′ 
Slope (age^2: team)   0.042′, 0.06 0.047, 0.07′ 0.053, 0.06′ 0.056′, 0.06′ 
Slope (CAN Score: team)   0.078′, 0.09′ 0.072′, 0.1′ 0.069′, 0.09′ 0.066′, 0.09′ 
Slope (CAN Score^(0.5): 
team)   0.037, 0.05′ 0.042′, 0.04′ 0.038′, 0.04 0.041, 0.05′ 
Slope (insurance: facility)   0.051′, 0.06′ 0.047′, 0.07′ 0.049′, 0.06′ 0.045′, 0.07′ 
Slope (changed provider 
count: facility) 
    0.053′, 0.06′ 0.046′, 0.05′ 
Model Fit        
DIC 461019.6 227245.2 225469.7 225411.4 225351.3 225337.8 
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Multivariate  Univariate 
PC Non-PC  PC Non-PC 
Mean 0.431 1.023  0.514 1.083 
Median 0.381 0.977  0.439 1.058 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Facility Team Patient DIC 
2 2 2 225337.8 – 227448.1 
2 2 1 225491.7 – 225494.1 
2 1 2 225401.1 – 225396.9 
2 1 1 225582.5 – 225580.3 
1 2 2 225378.5 – 225375.7 
1 2 1 225444.9 – 225441.2 
1 1 2 225457.8 – 225460.5 
1 1 1 225550.7 – 225554.0 
Table 7: Goodness-of-fit values for the two scenarios 
 
Table 8: Summary statistics for the range of joint correct intervals 
